- Home
- KZR vs PRME Comparison
KZR vs PRME Comparison
Compare KZR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- PRME
- Stock Information
- Founded
- KZR 2015
- PRME 2019
- Country
- KZR United States
- PRME United States
- Employees
- KZR N/A
- PRME N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- PRME Medicinal Chemicals and Botanical Products
- Sector
- KZR Health Care
- PRME Health Care
- Exchange
- KZR Nasdaq
- PRME Nasdaq
- Market Cap
- KZR 29.7M
- PRME 693.5M
- IPO Year
- KZR 2018
- PRME 2022
- Fundamental
- Price
- KZR $3.95
- PRME $4.07
- Analyst Decision
- KZR Hold
- PRME Buy
- Analyst Count
- KZR 2
- PRME 6
- Target Price
- KZR $9.00
- PRME $8.88
- AVG Volume (30 Days)
- KZR 35.9K
- PRME 2.9M
- Earning Date
- KZR 11-11-2025
- PRME 11-11-2025
- Dividend Yield
- KZR N/A
- PRME N/A
- EPS Growth
- KZR N/A
- PRME N/A
- EPS
- KZR N/A
- PRME N/A
- Revenue
- KZR N/A
- PRME $4,961,000.00
- Revenue This Year
- KZR N/A
- PRME $179.58
- Revenue Next Year
- KZR N/A
- PRME N/A
- P/E Ratio
- KZR N/A
- PRME N/A
- Revenue Growth
- KZR N/A
- PRME 739.42
- 52 Week Low
- KZR $3.62
- PRME $1.11
- 52 Week High
- KZR $9.18
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- KZR 46.17
- PRME 58.95
- Support Level
- KZR $3.76
- PRME $3.09
- Resistance Level
- KZR $4.09
- PRME $4.18
- Average True Range (ATR)
- KZR 0.14
- PRME 0.27
- MACD
- KZR 0.02
- PRME 0.08
- Stochastic Oscillator
- KZR 42.22
- PRME 89.91
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.